Wed, Oct 12, 2022
Given a well laid out organic growth roadmap and relatively cheaper valuations, CLSA prefers UltraTech over Ambuja as it gives Outperform rating to the former and Sell stance to the latter.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.